UBS Maintains Buy on Edwards Lifesciences, Raises Price Target to $118
Benzinga Newsdesk 1 hour ago
Analyst RatingsNewsPrice TargetHot
UBS analyst Patrick Wood maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $110 to $118.
UBS analyst Patrick Wood maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $110 to $118.